Rare diseases
Investigational molecules
Locations
The Pearce Building, West Street, SL6 1RL, United Kingdom
Zogenix International Limited focuses on clinical research in CDKL5 deficiency disorder, Dravet syndrome, and Lennox-Gastaut syndrome, with an emphasis on seizure-related conditions affecting both children and adults.
The sponsor’s trial portfolio reflects interest in severe epilepsy and developmental epileptic encephalopathies that require ongoing therapeutic management.
Zogenix International Limited runs clinical trials in conditions such as CDKL5 deficiency disorder, Severe myoclonic epilepsy of infancy, Lennox-Gastaut syndrome, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Austria
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
